Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) hit a new 52-week low during trading on Friday . The stock traded as low as $6.76 and last traded at $7.15, with a volume of 3009987 shares traded. The stock had previously closed at $7.53.
Analysts Set New Price Targets
TDOC has been the topic of a number of recent research reports. Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Bank of America upped their price target on Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a report on Wednesday, February 12th. Piper Sandler decreased their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Finally, Oppenheimer cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a research report on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Teladoc Health has a consensus rating of "Hold" and a consensus target price of $11.26.
Get Our Latest Analysis on TDOC
Teladoc Health Stock Up 10.1 %
The firm has a market capitalization of $1.37 billion, a price-to-earnings ratio of -1.37 and a beta of 1.73. The business has a 50 day moving average of $9.85 and a 200 day moving average of $9.71. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.
Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, equities analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.
Insiders Place Their Bets
In related news, insider Adam C. Vandervoort sold 11,011 shares of the company's stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 0.95% of the company's stock.
Institutional Trading of Teladoc Health
A number of hedge funds have recently modified their holdings of TDOC. Vanguard Group Inc. grew its stake in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock valued at $167,830,000 after acquiring an additional 1,029,829 shares during the period. Point72 Asset Management L.P. grew its holdings in shares of Teladoc Health by 33.6% during the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after buying an additional 2,813,568 shares in the last quarter. Renaissance Technologies LLC grew its position in Teladoc Health by 15.5% in the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after purchasing an additional 763,265 shares in the last quarter. Geode Capital Management LLC raised its holdings in Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after acquiring an additional 22,664 shares in the last quarter. Finally, Maple Rock Capital Partners Inc. grew its stake in shares of Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.
Teladoc Health Company Profile
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
